share_log

新興市場銘柄ダイジェスト:サイジニアは反発、リボミックが一時ストップ高

Emerging Market Stock Digest: Cygnia rebounds, Ribomik hits temporary trading halt.

Fisco Japan ·  Jul 2 14:16

<6031> Cygnia 956 +54

Rebound. ZETA, a group company, announced that the recommendation engine ZETA RECOMMEND has been introduced to the comprehensive online store 'Goldwin Online Store' operated by Goldwin, which is considered a good material. The site already has the EC product search and site search engine 'ZETA SEARCH' installed, and supports the improvement of CX through both products. The 'ZETA CX series' consists of eight lineups and realizes further high-quality purchasing experiences through advanced data analysis and matching technology.

<4258> Amiya 2451 +128

Rebound. After the end of trading on the first day, they announced that they have signed a sales agency contract for the company's service 'Network All Cloud' with Canon Marketing Japan for the purpose of solving the problem of IT personnel shortage, which is considered a good material. Canon MJ started selling it from July 1. 'Network All Cloud' is a cloud service that can directly solve the problem of labor shortage by centrally managing and automatically controlling IT infrastructure nationwide. Canon MJ aims to further expand sales through its strong sales structure.

<2934> J Frontier 3145 +55

Announced that it has signed a business partnership agreement with LIGHT and is well received. J Frontier will sell the rapid test kit for lifestyle diseases 'SUGUME'. In addition, they will guide 'SOKUYAKU' online medical checkups for customers who purchase 'SUGUME'. Users can receive services from testing for illnesses to online medical treatment, medication guidance, and prescription drug delivery while at home or in the office by utilizing 'SUGUME' and 'SOKUYAKU'.

<5131> Linkers 214 -5

After rising in the morning, the price turned into congestion. After the end of the trading day on 1st, it was announced that Linkers for Bank, a business matching system for financial institutions, will be introduced to Fukui Bank. The company has already introduced the system to 42 institutions since its launch and is expanding its network across the country. The share price is expected to rebound if the company can recover the growth of the existing stores and make bullish announcements of product sales to new car dealerships.

<166A> Tasco HD 624 +11

Up. ZISEDAl, a subsidiary of the company, has obtained a patent for the architecture plan generation AI service TASUKI TECH TOUCH & PLAN and has started providing it to real estate developers. TOUCH & PLAN can calculate the volume check (volume rate survey, etc.) in about 5 minutes per item, and can significantly reduce the time and cost compared to conventional volume check operations (1 account monthly fee of 100,000 yen), realizing the homogenization of skills of purchasing officials and faster business consideration.

<4591> Ribomic 108 +15

The stock temporarily hit its maximum limit. The enrollment of patients for the Phase II clinical trial of umedaptanib pegol (anti-FGF2 aptamer), a treatment for cartilage agenesis in pediatric patients (aged 5 to 14), has been completed, and high-dose subcutaneous administration trials (cohort 2) have begun for patients who have completed the observation trial, resulting in a favorable response. There are currently no safety concerns raised in the ongoing Phase II clinical trial and Phase II long-term administration trial.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment